Hot Pursuit     18-Jul-22
NIIT Ltd leads losers in 'A' group
Bhansali Engineering Polymers Ltd, Zydus Lifesciences Ltd, EPL Ltd and Laurus Labs Ltd are among the other losers in the BSE's 'A' group today, 18 July 2022.

Bhansali Engineering Polymers Ltd, Zydus Lifesciences Ltd, EPL Ltd and Laurus Labs Ltd are among the other losers in the BSE's 'A' group today, 18 July 2022.

NIIT Ltd tumbled 7.28% to Rs 352.75 at 14:47 IST.The stock was the biggest loser in the BSE's 'A' group.On the BSE, 1.12 lakh shares were traded on the counter so far as against the average daily volumes of 28981 shares in the past one month.

Bhansali Engineering Polymers Ltd lost 4.81% to Rs 106.9. The stock was the second biggest loser in 'A' group.On the BSE, 1.61 lakh shares were traded on the counter so far as against the average daily volumes of 50339 shares in the past one month.

Zydus Lifesciences Ltd crashed 3.44% to Rs 358.4. The stock was the third biggest loser in 'A' group.On the BSE, 1.61 lakh shares were traded on the counter so far as against the average daily volumes of 32623 shares in the past one month.

EPL Ltd dropped 3.07% to Rs 176.95. The stock was the fourth biggest loser in 'A' group.On the BSE, 18644 shares were traded on the counter so far as against the average daily volumes of 10543 shares in the past one month.

Laurus Labs Ltd fell 3.00% to Rs 506.85. The stock was the fifth biggest loser in 'A' group.On the BSE, 53981 shares were traded on the counter so far as against the average daily volumes of 54393 shares in the past one month.

Previous News
  Bhansali Engineering Polymers to convene board meeting
 ( Corporate News - 17-Apr-25   12:52 )
  Zydus Lifesciences Ltd leads losers in 'A' group
 ( Hot Pursuit - 16-Apr-25   15:00 )
  NIIT allots 16,002 equity shares under ESOP
 ( Corporate News - 15-Apr-25   19:51 )
  Zydus receives USFDA approval for Jaythari® (Deflazacort) Tablets
 ( Corporate News - 12-Apr-25   13:35 )
  Zydus Life gets USFDA nod for Deflazacort tablets to treat Duchenne muscular dystrophy
 ( Hot Pursuit - 12-Apr-25   10:22 )
  Zydus Life receives USFDA approval for manufacturing Apalutamide tablets, 60 mg
 ( Hot Pursuit - 19-Mar-25   09:32 )
  Zydus Lifesciences receives USFDA approval for Apalutamide Tablets, 60 mg
 ( Corporate News - 18-Mar-25   19:40 )
  Zydus Life gains as Gujarat facility clears USFDA inspection with zero observations
 ( Hot Pursuit - 17-Mar-25   09:49 )
  Zydus' Ankleshwar unit successfully completes USFDA inspection
 ( Corporate News - 15-Mar-25   11:27 )
  Zydus Life’s Gujarat facility clears USFDA inspection with zero observations
 ( Hot Pursuit - 15-Mar-25   10:19 )
  Zynext Ventures invests in Illexcor Therapeutics
 ( Corporate News - 13-Mar-25   12:21 )
Other Stories
  HDFC Bank Q4 PAT rises 7% YoY to Rs 17,616 cr; NII rises 10%
  19-Apr-25   18:04
  Yes Bank Q4 PAT climbs 63% YoY to Rs 738 cr
  19-Apr-25   16:20
  Mastek Q4 PAT slides 14% QoQ to Rs 81 cr; recommends final dividend of Rs 16/sh
  19-Apr-25   14:31
  Tata Elxsi posts PAT of Rs 172 crore in Q4; EBITDA margin at 20.5%
  19-Apr-25   12:47
  Mahindra EPC records more than fourfold rise in Q4 PAT
  19-Apr-25   11:04
  Just Dial Q4 PAT climbs 36% YoY to Rs 158 cr
  19-Apr-25   10:02
  Jio Financial Services Q4 PAT rises 2% YoY to Rs 316 cr
  19-Apr-25   08:57
  HDFC Life Q4 PAT climbs 16% YoY to Rs 476 cr
  17-Apr-25   17:32
  Infosys Q4 PAT rises 3% QoQ to Rs 7,038 cr; declares dividend of Rs 22/sh
  17-Apr-25   17:25
  HDFC AMC rises after Q4 PAT jumps 18% YoY to Rs 639 cr; declares final dividend of Rs 90/sh
  17-Apr-25   17:11
Back Top